CD4 and cancer: However, we did not observe these effects in CD4+ T cells except for the reduction of Pd‐1 in cancer tissues from 4T1‐sh‐mR1#1 cells compared to that from 4T1‐sh‐Ctrl cells (Figure S3D,E, Supporting Information).